Journal
/
Inmunología y contagio
/
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
JoVE Revista
Inmunología y contagio
This content is Free Access.
JoVE Revista Inmunología y contagio
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

11,772 Views

•

09:38 min

•

September 12, 2016

DOI:

10.3791/54348-v

DOI:
10.3791/54348-v

•

09:38 min
September 12, 2016

•

1 Views
, , , ,
1Physical Medicine and Rehabilitation,University of Alabama at Birmingham, 2Department of Pathology,University of Alabama at Birmingham, 3Department of Neurobiology,University of Alabama at Birmingham, 4Center for Glial Biology and Medicine,University of Alabama at Birmingham

Summary

Automatically generated

This protocol describes how to determine whether pharmacological treatments for experimental autoimmune encephalomyelitis show CNS protection as a consequence of suppressing immune cell infiltration or are neuroprotective during the onslaught of immune cell infiltration.

Explore More Videos

Immune System SuppressionCNS ProtectionPharmacological InterventionsAutoimmune DemyelinationExperimental Autoimmune Encephalomyelitis (EAE)Multiple SclerosisSystem Xc-transporter InhibitorCell IsolationDensity GradientMyelinCell CultureRestimulation

Read Article

Cite this Article

Evonuk, K. S., Moseley, C. E., Doyle, R. E., Weaver, C. T., DeSilva, T. M. Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination. J. Vis. Exp. (115), e54348, doi:10.3791/54348 (2016).

Download .ris file

Copy

Share Video

.

Copy